Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00230451 · ClinicalTrials.gov registry record · Phase 2
Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma
A Phase 2 study, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00230451: Completed Phase 2 study, sponsored by University of Michigan Rogel Cancer Center.
NCT00230451 is a Phase 2 study that has completed, run by University of Michigan Rogel Cancer Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00230451, a Phase 2 study, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
Surgery (esophagectomy or removal of the esophagus)has been the standard treatment for cancer of the esophagus. However, evidence suggests that preoperative chemotherapy and radiation therapy may add benefit. The purpose of this study is to determine if a treatment program of combined chemotherapy and radiation therapy prior to surgery and chemotherapy after surgery will delay or eliminate recurrence of the cancer.
Interventions
- DRUG Cisplatin
- DRUG Paclitaxel
- DRUG 5-Fluorouracil
- PROCEDURE Radiation
Trial Details
| Field | Value |
|---|---|
| Start Date | 1997-11 |
| Est. Completion | 2008-07 |
| Phase | Phase 2 |
What the finished NCT00230451 record still lists
NCT00230451 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 4 interventions - of which Cisplatin is the first listed.
NCT00230451 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00230451 about?
NCT00230451 is a clinical study titled "Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma". Surgery (esophagectomy or removal of the esophagus)has been the standard treatment for cancer of the esophagus. However, evidence suggests that preoperative chemotherapy and radiation therapy may add benefit. The purpose of this study is to determine if a treatment program of combined chemotherapy a...
What is the current status of trial NCT00230451?
This trial is currently completed. It is a Phase 2 study. The study started on 1997-11. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00230451?
The interventions under investigation include: Cisplatin (DRUG), Paclitaxel (DRUG), 5-Fluorouracil (DRUG), Radiation (PROCEDURE).
Who is sponsoring clinical trial NCT00230451?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia